M

Medicofarma Biotech SA
WSE:MDB

Watchlist Manager
Medicofarma Biotech SA
WSE:MDB
Watchlist
Price: 0.383 PLN 1.06% Market Closed
Market Cap: 26m PLN
Have any thoughts about
Medicofarma Biotech SA?
Write Note

Medicofarma Biotech SA
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Medicofarma Biotech SA
Cost of Revenue Peer Comparison

Comparables:
I
IGN
R
RVU
S
SLV

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
M
Medicofarma Biotech SA
WSE:MDB
Cost of Revenue
-zł259.4k
CAGR 3-Years
55%
CAGR 5-Years
41%
CAGR 10-Years
N/A
I
Inno-Gene SA
WSE:IGN
Cost of Revenue
-zł666k
CAGR 3-Years
51%
CAGR 5-Years
-6%
CAGR 10-Years
13%
R
Ryvu Therapeutics SA
WSE:RVU
Cost of Revenue
-zł21.3m
CAGR 3-Years
-28%
CAGR 5-Years
20%
CAGR 10-Years
-6%
S
Selvita SA
WSE:SLV
Cost of Revenue
-zł70.1m
CAGR 3-Years
0%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Medicofarma Biotech SA's Cost of Revenue?
Cost of Revenue
-259.4k PLN

Based on the financial report for Dec 31, 2023, Medicofarma Biotech SA's Cost of Revenue amounts to -259.4k PLN.

What is Medicofarma Biotech SA's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
41%

Over the last year, the Cost of Revenue growth was 92%. The average annual Cost of Revenue growth rates for Medicofarma Biotech SA have been 55% over the past three years , 41% over the past five years .

Back to Top